Search

The neural circuits controlling feeding and emotional behaviors are intricately and reciprocally connected. Recent technological developments, including cell type-specific optogenetic and chemogenetic approaches, allow functional characterization of genetically defined cell populations and neural circuits in feeding and emotional processes. Here we review recent studies that have utilized circuit-based manipulations to decipher the functional interactions between neural circuits controlling feeding and those controlling emotional processes. Specifically, we highlight newly described neural circuit interactions between classical emotion-related brain regions, such as the hippocampus and amygdala, and homeostatic feeding circuitry in the arcuate nucleus and lateral hypothalamus (LH). Together these circuits will provide a template for future studies to examine functional interactions between feeding and emotion. [ABSTRACT FROM AUTHOR]

Needle coke has attracted much attention as soft carbon anode material for potassium-ion batteries (PIBs) owing to its high crystallinity and conductivity. However, limited research has been conducted on the storage mechanism and the functional and structural evolution of the solid electrolyte interphase (SEI) in ester and ether based electrolytes. This work investigates the potassium ion storage mechanisms of soft carbon anodes in three electrolytes: KPF 6 EC/DEC, KPF 6 DME, and KFSI DME, and reveals that K+ stored in the KPF 6 EC/DEC electrolyte could be through an "adsorption-intercalation" mechanism. Whereas K+ stored in the DME-based electrolytes is believed to undergo a "co-intercalation/adsorption-intercalation" process. Interfacial analyses indicate that the SEI formed in the EC/DEC electrolyte inhibits co-intercalation of potassium ion and solvent, which preserves sufficient space to accommodate potassium ion. Conversely, the [K-DME]+ solvation co-intercalation in DME-based electrolytes compromises the structural integrity, and results in a persistent capacity decline. This work offers novel insights into potassium ion storage in ester and ether-based electrolytes, and provides theoretical support for the fabrication of high-performance soft carbon anodes. The storage mechanism and interfacial evolution of needle coke anodes for potassium-ion batteries were systematically investigated by using KPF 6 EC/DEC, KPF 6 DME, and KFSI DME electrolytes. [Display omitted] [ABSTRACT FROM AUTHOR]

This study aims to investigate the relationship between DNA methylation and expression of human dopamine transporter ( hDAT ). We examined methylation status of hDAT in cells with various hDAT expression levels, including two dopaminergic neural cell lines (SK-N-AS and SH-SY-5Y) and one non-dopaminergic cell line (HEK293) by bisulfite sequencing PCR(BSP). The effects of DNA methyltransferase inhibitor 5-aza-dC or/and histone deacetylase inhibitor (HDACi, sodium butyrate, NaB) on the DNA methylation status and mRNA expression levels of hDAT were examined. The results revealed marked hypomethylation of the two promoter regions (−1214 to −856 bp and −48 to 439 bp, the first base of exon 1 was taken as +1 bp)of hDAT in SK-N-AS (4.7% ± 2.0 mC and 3.5% ± 1.0 mC , respectively) compared with SH-SY-5Y (88.0% ± 4.4% mC and 81.1% ± 8.8% mC ) and HEK293 (90.7% ± 2.4 mC and 84.4% ± 8.6% mC ) cell lines, indicating a cell-specific methylation regulation of hDAT . 5-aza-dC and NaB decreased hypermethylation,while increase hDAT expression in SH-SY-5Y cells and recovered hDAT mRNA expression in HEK293 cells. DNA methylation enabled the cell-specific differential expression of the hDAT gene. hDAT silencing was reversed by the introduction of DNA hypomethylation via 5-aza-dC or/and NaB. [ABSTRACT FROM AUTHOR]

Objective: It is well established that schizophrenia patients have high cardiovascular morbidity and mortality. However, the underlying risk factors in the earliest stages of both schizophrenia illness and antipsychotics treatment are less clear. This study aimed to characterize the metabolic features of those patients.Methods: We performed a retrospective cohort study in a naturalistic setting, which included antipsychotic-naïve, first-episode schizophrenia (FES) inpatients with the baseline metabolic measurements and changes following a short term treatment with antipsychotic drugs.Results: Although prevalence of hypertriglyceridemia, hypercholesterolemia, higher-LDL-C and hyperglycaemia in patients with FES were much lower than those of the general population (7.5% v.s. 14.9%, 9.2% v.s. 18.4%, 8.1% v.s. 14.9%, 8.6% v.s.18.3%, respectively), lower-HDL-C in patients with FES were much more prevalent than that of the general population (19.9% v.s. 6.4%). Despite significant metabolic risk profiles (as such lipid abnormalities and insulin resistance) increase, mean fasting glucose and glucosylated serum protein (GSP) were significantly decreased after the short term (median of 23days) antipsychotics exposure, compared to baseline. There is no significant difference of the metabolic profile change between monopharmacy and polypharmacy.Conclusion: These results indicated an early-onset nature of HDL-C abnormalities in drug-naïve FES patients. Lipids metabolism risk may develop early and quickly after antipsychotic exposure. Early monitoring is required for the purpose of early detection and hence prevention of the initial metabolic risk which may lead to diabetes mellitus and cardiovascular disease. [ABSTRACT FROM AUTHOR]